đź’¨ Abstract
Bluebird Bio Inc. reported a Q1 loss of $29.1 million, or $2.98 per share. Adjusted for restructuring costs, the loss was $2.66 per share. The company's revenue was $38.7 million. Shares closed at $4.98, down from $21.40 a year ago.
Courtesy: wtop.com
Suggested
Dodgers call up top prospect Dalton Rushing and cut loose veteran catcher Austin Barnes -
Russell-Rowe’s goal pushes Columbus Crew to 1-1 draw against feisty CF Montreal -
DC United’s Luis Barraza, NYCFC’s Matt Freese duel to scoreless draw -
The top photos of the day by AP’s photojournalists -
Stowers homers twice, Weathers strong in return to lead Marlins over Cubs 3-1 -
The Twins turned their season around. The Orioles are showing few signs of doing that -
Panthers rout the Maple Leafs 6-1 to take a 3-2 series lead -
Davis Martin helps the White Sox beat the slumping Reds 4-2 -
Chiefs-Eagles Super Bowl rematch in Week 2, Allen-Jackson showdown in Week 1 highlight NFL schedule -
Rubio and other top NATO diplomats meet in Turkey ahead of possible Ukraine-Russia talks -